Takeda draws investor scrutiny for CEO's $93m 10-year payout

Japan pharma maker underperformed under Weber, critics say

20240626N Takeda

Christophe Weber has been president of Takeda Pharmaceuticals for a decade after becoming the first foreign-born head of the Japanese drugmaker. (Source photos by Nikkei)

HINAKO BANNO and TAITO KUROSE, Nikkei staff writers

TOKYO -- In the 10 years Christophe Weber has been president of Takeda Pharmaceutical, the Japanese drugmaker has more than doubled its revenue and he has earned just over 15 billion yen ($93.4 million) in total executive compensation.

Sponsored Content

About Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.